Murine mast cells secrete and respond to interleukin-33

Journal of Interferon and Cytokine Research

Volumn 34, Issue 3, 2014, Pages 141-147

  Tung, Hui Ying ^a   Plunkett, Beverly ^a   Huang, Shau Ku ^a,b   Zhou, Yufeng ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OVALBUMIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; MAST CELL; MOUSE; MURINAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SUPERNATANT;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; IMMUNOGLOBULIN E; INTERLEUKIN-13; INTERLEUKIN-6; INTERLEUKINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAST CELLS; MICE; MICE, INBRED C57BL; NF-KAPPA B; OVALBUMIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, INTERLEUKIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9;

EID: 84895882458     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0066     Document Type: Article

References (36)

1. Baekkevold ES, Roussigne M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M, Haraldsen G, Girard JP. 2003. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163(1):69-79
2. Beech JT, Bainbridge T, Thompson SJ. 1997. Incorporation of cells into an ELISA system enhances antigen-driven lymphokine detection. J Immunol Methods 205(2):163-168
3. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP. 2007. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-Associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104(1):282-287
4. Cassel SL, Joly S, Sutterwala FS. 2009. The NLRP3 inflammasome: A sensor of immune danger signals. Semin Immunol 21(4):194-198
5. Cayrol C, Girard JP. 2009. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 106(22):9021-9026
6. Dinarello CA. 2005. An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity 23(5):461-462
7. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. 2002. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3(10):944-950
8. Gadina M, Jefferies CA. 2007. IL-33: A sheep in wolf's clothing? Sci STKE 2007(390):pe31
9. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Kuchler AM. 2009. Interleukin-33-cytokine of dual function or novel alarmin? Trends Immunol 30(5):227-233
10. Hattar K, Fink L, Fietzner K, Himmel B, Grimminger F, Seeger W, Sibelius U. 2001. Cell density regulates neutrophil IL-8 synthesis: Role of IL-1 receptor antagonist and soluble TNF receptors. J Immunol 166(10):6287-6293
11. Hayakawa H, Hayakawa M, Kume A, Tominaga S. 2007. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282(36):26369-26380
12. Ho LH, Ohno T, Oboki K, Kajiwara N, Suto H, Iikura M, Okayama Y, Akira S, Saito H, Galli SJ, Nakae S. 2007. IL-33 induces IL-13 production by mouse mast cells independently of IgE-Fc epsilon RI signals. J Leuk Biol 82(6):1481-1490
13. Hogaboam C, Kunkel SL, Strieter RM, Taub DD, Lincoln P, Standiford TJ, Lukacs NW. 1998. Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J Immunol 160(12):6166-6171
14. Hsu CL, Neilsen CV, Bryce PJ. 2010. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 5(8):e11944
15. Kakkar R, Lee RT. 2008. The IL-33/ST2 pathway: Therapeutic target and novel biomarker. Nat Rev Drug Discov 7(10):827-840
16. Lamkanfi M, Dixit VM. 2009. IL-33 raises alarm. Immunity 31(1):5-7
17. Liew FY, Pitman NI, McInnes IB. 2010. Disease-Associated functions of IL-33: The new kid in the IL-1 family. Nat Rev Immunol 10(2):103-110
18. Matsushima H, Yamada N, Matsue H, Shimada S. 2004. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 173(1):531-541
19. McCurdy JD, Lin TJ, Marshall JS. 2001. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70(6):977-984
20. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H. 2011. Human IL-25-And IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12(11):1055-1062
21. Mollenhauer HH, Morre DJ, Rowe LD. 1990. Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity. Biochim Biophys Acta 1031(2):225-246
22. Ohno T, Oboki K, Kajiwara N, Morii E, Aozasa K, Flavell RA, Okumura K, Saito H, Nakae S. 2009. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J Immunol 183(12):7890-7897
23. Palmer G, Gabay C. 2011. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol 7(6): 321-329
24. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 23(5):479-490
25. Seidelin JB, Rogler G, Nielsen OH. 2011. A role for interleukin-33 in T(H)2-polarized intestinal inflammation? Mucosal Immunol 4(5):496-502
26. Smith DE. 2010. IL-33: A tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 40(2):200-208
27. Smith DE. 2011. The biological paths of IL-1 family members IL-18 and IL-33. J Leukoc Biol 89(3):383-392
28. Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, Ra C, Ogawa H. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109(10):1351-1359
29. Tago K, Noda T, Hayakawa M, Iwahana H, Yanagisawa K, Yashiro T, Tominaga S. 2001. Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V. Biochem Biophys Res Commun 285(5):1377-1383
30. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G. 2009. Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 284(29):19420-19426
31. Varadaradjalou S, Feger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, Arock M. 2003. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 33(4):899-906
32. Yanagawa Y, Suzuki M, Matsumoto M, Togashi H. 2011. Prostaglandin E(2) enhances IL-33 production by dendritic cells. Immunol Lett 141(1):55-60
33. Yang Z, Marshall JS. 2009. Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. Immunobiology 214(4):321-330
34. Zhao W, Hu Z. 2010. The enigmatic processing and secretion of interleukin-33. Cell Mol Immunol 7(4):260-262
35. Zhou Y, Kawasaki H, Hsu SC, Lee RT, Yao X, Plunkett B, Fu J, Yang K, Lee YC, Huang SK. 2010. Oral tolerance to foodinduced systemic anaphylaxis mediated by the C-Type lectin SIGNR1. Nat Med 16(10):1128-1133
36. Zhou Y, Tung HY, Tsai YM, Hsu SC, Chang HW, Kawasaki H, Tseng HC, Plunkett B, Gao P, Hung CH, Vonakis BM, Huang SK. 2013. Aryl hydrocarbon receptor controls murine mast cell homeostasis. Blood 121(16):3195-3204